#202 Raphael Townshend: How AI and RNA Tech is Transforming Drug Discovery (Inside Atomic AI)
In this episode of the Eye on AI podcast, we explore the cutting-edge intersection of AI and biotechnology with Raphael Townshend, founder and CEO of Atomic AI. Raphael delves into the revolutionary potential of AI in RNA drug discovery, highlighting Atomic AI's innovative approach. He shares his journey from studying…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Eye On A.I.
See all episodes →
57%Inside Ukraine's Azov Drone R&D: The Engineer Building AI Weapons 18 km From the Front Line | Alexander Palamarchuk
56%Inside Ukraine's Drone War: Maj. "Phoenix" of Lasar's Group
55%From 10 Drones a Month to Nearly 100,000 — Inside Ukraine's Largest Drone Manufacturer | Marko Kushnir, General Cherry
Similar episodes from other shows
More like Eye On A.I. →
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
EP 27: AI Revolutionizing Drug Discovery (2023 - 2025)
🔬Beyond AlphaFold: How Boltz is Open-Sourcing the Future of Drug Discovery
AlphaFold is revolutionizing biology
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.